• UK Study Demonstrates Real-World Value of Genetic Testing for Drug Prescribing

    Bio-IT World | The UK's National Health Service is pioneering a new approach to precision medicine through pharmacogenomic testing that could transform how doctors prescribe medications and significantly reduce healthcare costs. Early results from the NHS PROGRESS trial suggest that genetic testing can guide prescribing decisions for nearly all patients, with one in four participants having their prescriptions adjusted for safer or more effective treatment.

    Jun 26, 2025

  • Follow the Money: ITM’s Gastroenteropancreatic Therapy, GRIN, Angelini Pharma Collaborates, More

    Bio-IT World | ITM plans to use their financing to prepare for commercial readiness and potential market launch of the company’s lead candidate, n.c.a. 177Lu-edotreotide, which treats gastroenteropancreatic neuroendocrine tumors; GRIN and Angelini Pharma will develop and expand commercial rights outside of North America for GRIN's investigational drug radiprodil, which treats rare genetic epilepsies and neurodevelopmental disorders; and more.

    Jun 25, 2025

  • Pangaea Data, Alexion Collaboration, Dell to Develop Supercomputer, More

    Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

    Jun 24, 2025

  • Nanoneedle Patch Enables Non-Invasive Tissue Sampling Offering Spatiotemporal Insights

    Bio-IT World | Nanoneedle technology developed by researchers from King’s College London offers the ability to extract molecular information from living tissue without damaging or killing cells—offering spatial and longitudinal molecular insights that is described as a “fundamental scientific breakthrough.”

    Jun 19, 2025